arrow
X

Xavier Brazzolotto

universidade de santiago de compostela
H指数:27
被引数:3,212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, synthesis and biological evaluation of pleiotropic prodrugs activated by cholinesterases and releasing a 5-HT4R agonist, with in vivo antiamnesic activity.

设计、合成及生物学评价:经胆碱酯酶激活并释放5-HT<sub>4</sub>R激动剂、具有体内抗遗忘活性的多效前药

2026-10-100
OAAI
Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes

利用多靶点BChE-MAO B抑制剂对抗小胶质细胞相关神经炎症:体外生物评价、构效关系、类药性以及X射线晶体复合物

2026-09-291
PRE
Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer’s disease model.

获得新型强效多效性前药,其靶向丁酰胆碱酯酶和血清素再摄取,并在阿尔茨海默病模型中具有抗遗忘活性。

2026-02-120
PRE
Dual Cholinergic Modulation in Dementia: Quinuclidine Carbamates Targeting Butyrylcholinesterase and α7 Nicotinic Receptor

痴呆症的双胆碱能调节:靶向丁酰胆碱酯酶和α7烟碱型受体喹啉环碳酸酯类化合物

2025-11-150
PRE
Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease
2024-11-220
OA
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
2023-05-0118
OAAI
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids- Design, synthesis, and biological evaluation
2023-04-016
PRE
Discovery of new, highly potent and selective inhibitors of BuChE- design synthesis, in vitro and in vivo evaluation and crystallography studies

发现新的,高效和选择性的BuChE抑制剂-设计合成,体外和体内评估和晶体学研究

2023-03-018
PRE
Pseudo-irreversible butyrylcholinesterase inhibitors: Structure-activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead

假不可逆丁酰胆碱酯酶抑制剂: N-二烷基O-芳基氨基甲酸酯弹头的构效关系,计算和晶体学研究

2023-02-016
PRE